{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T23:10:12Z","timestamp":1759619412765,"version":"build-2065373602"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,4]]},"DOI":"10.7759\/cureus.93839","type":"journal-article","created":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T22:43:01Z","timestamp":1759617781000},"source":"Crossref","is-referenced-by-count":0,"title":["Severe Seronegative Myasthenia Gravis Revealed by Rapidly Progressive Dysphagia"],"prefix":"10.7759","author":[{"given":"Christopher","family":"Ramos Huamancondor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maroussia","family":"Bronchain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Petit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.aforl.2014.07.133","article-title":"Acute dysphagia inaugurating a myasthenic crisis requiring resuscitation. (Article in French)","volume":"131","author":"Tanaka L","year":"2014","unstructured":"Tanaka L, Gharzouli I, Le Clerc N, Cloutier T, Salvan D. Acute dysphagia inaugurating a myasthenic crisis requiring resuscitation. (Article in French). Ann Fr Oto-Rhino-Laryngol Pathol Cerv-Fac. 2014, 131:49. 10.1016\/j.aforl.2014.07.133","journal-title":"Ann Fr Oto-Rhino-Laryngol Pathol Cerv-Fac"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2014-204163","article-title":"Myasthenia gravis masquerading as dysphagia: unveiled by magnesium infusion","volume":"2014","author":"Klair JS","year":"2014","unstructured":"Klair JS, Rochlani YM, Meena NK. Myasthenia gravis masquerading as dysphagia: unveiled by magnesium infusion. BMJ Case Rep. 2014, 2014:bcr2014204163. 10.1136\/bcr-2014-204163","journal-title":"BMJ Case Rep"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.30476\/jrsr.2022.93045.1221","article-title":"Dysphagia as a main symptom of myasthenia gravis in a middleaged adult male: a case report","volume":"10","author":"Sariaslani P","year":"2023","unstructured":"Sariaslani P, Homagostar G, Mohammadi H. Dysphagia as a main symptom of myasthenia gravis in a middleaged adult male: a case report. J Rehab Sci Res. 2023, 10:106-8. 10.30476\/jrsr.2022.93045.1221","journal-title":"J Rehab Sci Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.16880","article-title":"A rare presentation of a rare disease: oropharyngeal dysphagia as the main manifestation of myasthenia gravis","volume":"13","author":"Abudalou M","year":"2021","unstructured":"Abudalou M, Malkowski M, Robles MR, Vega EA, Slama MC. A rare presentation of a rare disease: oropharyngeal dysphagia as the main manifestation of myasthenia gravis. Cureus. 2021, 13:e16880. 10.7759\/cureus.16880","journal-title":"Cureus"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27832","article-title":"Myasthenic crisis","volume":"68","author":"Claytor B","year":"2023","unstructured":"Claytor B, Cho SM, Li Y. Myasthenic crisis. Muscle Nerve. 2023, 68:8-19. 10.1002\/mus.27832","journal-title":"Muscle Nerve"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-023-11733-y","article-title":"Myasthenia gravis, respiratory function, and respiratory tract disease","volume":"270","author":"Gilhus NE","year":"2023","unstructured":"Gilhus NE. Myasthenia gravis, respiratory function, and respiratory tract disease. J Neurol. 2023, 270:3329-40. 10.1007\/s00415-023-11733-y","journal-title":"J Neurol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1602678","article-title":"Myasthenia gravis","volume":"375","author":"Gilhus NE","year":"2016","unstructured":"Gilhus NE. Myasthenia gravis. N Engl J Med. 2016, 375:2570-81. 10.1056\/NEJMra1602678","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2017.06.009","article-title":"Myasthenia gravis and crisis: evaluation and management in the emergency department","volume":"53","author":"Roper J","year":"2017","unstructured":"Roper J, Fleming ME, Long B, Koyfman A. Myasthenia gravis and crisis: evaluation and management in the emergency department. J Emerg Med. 2017, 53:843-53. 10.1016\/j.jemermed.2017.06.009","journal-title":"J Emerg Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1201451","article-title":"Occurrence and severity of myasthenic crisis in an unselected Turkish cohort of patients with myasthenia gravis","volume":"14","author":"Ozyurt Kose S","year":"2023","unstructured":"Ozyurt Kose S, Nazli E, Tutkavul K, Gilhus NE. Occurrence and severity of myasthenic crisis in an unselected Turkish cohort of patients with myasthenia gravis. Front Neurol. 2023, 14:1201451. 10.3389\/fneur.2023.1201451","journal-title":"Front Neurol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/2050313X20986662","article-title":"Descending paralysis as an atypical presentation of Guillain-Barr\u00e9 Syndrome","volume":"9","author":"Mustafa A","year":"2021","unstructured":"Mustafa A, Adio B, Yarahmadi A. Descending paralysis as an atypical presentation of Guillain-Barr\u00e9 Syndrome. SAGE Open Med Case Rep. 2021, 9:2050313X20986662. 10.1177\/2050313X20986662","journal-title":"SAGE Open Med Case Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/s1474-4422(13)70215-1","article-title":"Axonal Guillain-Barr\u00e9 syndrome: concepts and controversies","volume":"12","author":"Kuwabara S","year":"2013","unstructured":"Kuwabara S, Yuki N. Axonal Guillain-Barr\u00e9 syndrome: concepts and controversies. Lancet Neurol. 2013, 12:1180-8. 10.1016\/s1474-4422(13)70215-1","journal-title":"Lancet Neurol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-025-13170-5","article-title":"Double seronegative myasthenia gravis and mimics: a retrospective cross-sectional study by two tertiary centers in the Southern Italy","volume":"272","author":"Maccora S","year":"2025","unstructured":"Maccora S, Vinciguerra C, Messina C, et al.. Double seronegative myasthenia gravis and mimics: a retrospective cross-sectional study by two tertiary centers in the Southern Italy. J Neurol. 2025, 272:433. 10.1007\/s00415-025-13170-5","journal-title":"J Neurol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/mus.28410","article-title":"Frequency and severity of myasthenia gravis exacerbations associated with the use of ciprofloxacin, levofloxacin, and azithromycin","volume":"71","author":"Uysal SP","year":"2025","unstructured":"Uysal SP, Li Y, Thompson NR, Li Y. Frequency and severity of myasthenia gravis exacerbations associated with the use of ciprofloxacin, levofloxacin, and azithromycin. Muscle Nerve. 2025, 71:1063-71. 10.1002\/mus.28410","journal-title":"Muscle Nerve"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27230","article-title":"Pharmacosafety of fluoroquinolone and macrolide antibiotics in the clinical care of patients with myasthenia gravis","volume":"64","author":"Pham Nguyen TP","year":"2021","unstructured":"Pham Nguyen TP, Leonard CE, Bird SJ, Willis AW, Hamedani AG. Pharmacosafety of fluoroquinolone and macrolide antibiotics in the clinical care of patients with myasthenia gravis. Muscle Nerve. 2021, 64:156-62. 10.1002\/mus.27230","journal-title":"Muscle Nerve"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000008688","article-title":"Myasthenic crisis demanding mechanical ventilation: a multicenter analysis of 250 cases","volume":"94","author":"Neumann B","year":"2020","unstructured":"Neumann B, Angstwurm K, Mergenthaler P, et al.. Myasthenic crisis demanding mechanical ventilation: a multicenter analysis of 250 cases. Neurology. 2020, 94:e299-313. 10.1212\/WNL.0000000000008688","journal-title":"Neurology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1055\/s-0036-1592106","article-title":"Getting rid of weakness in the ICU: an updated approach to the acute management of myasthenia gravis and Guillain-Barr\u00e9 syndrome","volume":"36","author":"Lizarraga AA","year":"2016","unstructured":"Lizarraga AA, Lizarraga KJ, Benatar M. Getting rid of weakness in the ICU: an updated approach to the acute management of myasthenia gravis and Guillain-Barr\u00e9 syndrome. Semin Neurol. 2016, 36:615-24. 10.1055\/s-0036-1592106","journal-title":"Semin Neurol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s12028-021-01259-4","article-title":"Acetylcholinesterase inhibitors in myasthenic crisis: a systematic review of observational studies","volume":"35","author":"Prado MB Jr","year":"2021","unstructured":"Prado MB Jr, Adiao KJ. Acetylcholinesterase inhibitors in myasthenic crisis: a systematic review of observational studies. Neurocrit Care. 2021, 35:528-44. 10.1007\/s12028-021-01259-4","journal-title":"Neurocrit Care"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s13760-024-02552-7","article-title":"Recommendations for the management of myasthenia gravis in Belgium","volume":"124","author":"De Bleecker JL","year":"2024","unstructured":"De Bleecker JL, Remiche G, Alonso-Jim\u00e9nez A, Van Parys V, Bissay V, Delstanche S, Claeys KG. Recommendations for the management of myasthenia gravis in Belgium. Acta Neurol Belg. 2024, 124:1371-83. 10.1007\/s13760-024-02552-7","journal-title":"Acta Neurol Belg"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000011124","article-title":"International consensus guidance for management of myasthenia gravis: 2020 update","volume":"96","author":"Narayanaswami P","year":"2021","unstructured":"Narayanaswami P, Sanders DB, Wolfe G, et al.. International consensus guidance for management of myasthenia gravis: 2020 update. Neurology. 2021, 96:114-22. 10.1212\/WNL.0000000000011124","journal-title":"Neurology"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/mus.28038","article-title":"How should newer therapeutic agents be incorporated into the treatment of patients with myasthenia gravis?","volume":"69","author":"Gwathmey KG","year":"2024","unstructured":"Gwathmey KG, Ding H, Hehir M, Silvestri N. How should newer therapeutic agents be incorporated into the treatment of patients with myasthenia gravis?. Muscle Nerve. 2024, 69:389-96. 10.1002\/mus.28038","journal-title":"Muscle Nerve"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/413224-severe-seronegative-myasthenia-gravis-revealed-by-rapidly-progressive-dysphagia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T22:43:02Z","timestamp":1759617782000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/413224-severe-seronegative-myasthenia-gravis-revealed-by-rapidly-progressive-dysphagia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,4]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.93839","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,4]]}}}